Thomas Rubio
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Epidemiology 14
- Pneumonia and Respiratory Infections 3
- Mycobacterium research and diagnosis 2
-
- Cystic Fibrosis Research Advances 6
- Co-authors
- Arnold L. Smith (3 shared papers)Dieter Adam (1 shared paper)Ron Dagan (1 shared paper)Y. Aujard (1 shared paper)Bettina C. Hilman (2 shared papers)Urs B. Schaad (2 shared papers)Mohammed Abdus Salam (1 shared paper)Richard B. Moss (2 shared papers)
- Journals
- The Journal of Pediatrics (8 papers)The Pediatric Infectious Disease Journal (5 papers)Journal of Antimicrobial Chemotherapy (2 papers)Pediatric Research (2 papers)Pediatric Pulmonology (1 paper)
- Partner nations
- United StatesSpainSwitzerland
In The Last Decade
Thomas Rubio
36 papers receiving 710 citations
Peers
Comparison fields: 5 of 85
- Molecular Medicine 110
- Pharmacology 198
- Applied Microbiology and Biotechnology 20
- Pulmonary and Respiratory Medicine 232
- Epidemiology 226
Countries citing papers authored by Thomas Rubio
This map shows the geographic impact of Thomas Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Rubio more than expected).
Fields of papers citing papers by Thomas Rubio
This network shows the impact of papers produced by Thomas Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Rubio. The network helps show where Thomas Rubio may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Rubio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 117 | |
| 2 | 1995 | 115 | |
| 3 | 1992 | 66 | |
| 4 | 1997 | 65 | |
| 5 | 1984 | 61 | |
| 6 | 1994 | 45 | |
| 7 | 1984 | 44 | |
| 8 | 1997 | 38 | |
| 9 | 1990 | 28 | |
| 10 | 1991 | 27 | |
| 11 | 1986 | 26 | |
| 12 | 2009 | 25 | |
| 13 | 1986 | 20 | |
| 14 | 1987 | 19 | |
| 15 | 2021 | 14 | |
| 16 | 1971 | 11 | |
| 17 | 1984 | 9 | |
| 18 | 1982 | 8 | |
| 19 | 2004 | 8 | |
| 20 | 1980 | 7 |
About Thomas Rubio
Thomas Rubio is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Infectious Diseases, Pharmacology and Surgery, having authored 39 papers that have together received 796 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Cystic Fibrosis Research Advances (6 papers), Pharmaceutical studies and practices (5 papers), Pneumonia and Respiratory Infections (3 papers), Neonatal Health and Biochemistry (3 papers), Neonatal and Maternal Infections (3 papers), Antibiotic Resistance in Bacteria (2 papers) and Mycobacterium research and diagnosis (2 papers). The work is most often cited by research in Molecular Medicine (110 citations), Pharmacology (198 citations), Applied Microbiology and Biotechnology (20 citations), Pulmonary and Respiratory Medicine (232 citations) and Epidemiology (226 citations). Thomas Rubio has collaborated with scholars based in United States, Spain and Switzerland. Frequent co-authors include Arnold L. Smith, Dieter Adam, Ron Dagan, Y. Aujard, Bettina C. Hilman, Urs B. Schaad, Mohammed Abdus Salam, Richard B. Moss, Heikki Peltola and Deborah Church. Their work appears in journals such as The Journal of Pediatrics, The Pediatric Infectious Disease Journal, Journal of Antimicrobial Chemotherapy, Pediatric Research and Pediatric Pulmonology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.